About 1 result found for searched term "1350624-75-7" (0.307 seconds)
Cat.No. | Name | Target |
---|---|---|
M24621 | Margetuximab | EGFR/HER2 |
Margetuximab (MGAH22) is a chimeric anti-HER2 monoclonal antibody optimized Fc domain, with an EC50 value of 39.33 ng/mL. Margetuximab can be used for researching metastatic HER2-positive breast cancer. |
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.